Author

Osama Wadah Rammaha

Institution: Hashemite University

Observed institution: Hashemite University

ORCID: 0009-0003-9764-8339

Observed ORCID: 0009-0003-9764-8339

OpenAlex ID: A5119438728

Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials

2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Figshare

Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials

2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Expert Opinion on Drug Safety

Abstract 3787: The safety of PARP inhibitors combined with immune checkpoint inhibitors versus immune checkpoint inhibitor monotherapy: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials

2026 · Mus'ab Theeb Mustafa, Aws Khalid Abushanab, et al. · Cancer Research

Impact of Medication Non-compliance among Hypertensive and Diabetic Patients in Jordan: A Prospective Cohort Study

2026 · Mohammad Hassan Al-Thnaibat, Mohammad Hijab alkubaisi, et al. · Current Hypertension Reviews

Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials

2025 · Zaher Mutaz Ashour, Aws Khalid Abushanab, et al. · Journal of Oncology Pharmacy Practice

Works count: 5

Citation count:

H-index:

I10-index: